Since 2007, BioPortUSA has had the pleasure of working with an number of different international life science companies on both the medical device and pharmaceutical side of things. The following are some of the companies we have worked with:
Headquartered in Dublin, Ireland, Allergan is a global pharmaceutical leader focused on the development, manufacture and commercialization of branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Chiesi USA is the U.S. affiliate of Chiesi Farmaceutici, S.p.A, a global R&D-focused pharmaceutical company located in Parma, Italy. We are a specialty pharmaceutical company committed to the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings.
Laborpharm is a dynamic laboratory service and supply company with a collective experience spanning over 70 years. For the past decade we’ve been supporting some of the biggest names across a range of industries, tapping into our team of consultants, experts, and factory-trained customer engineers.
For more than 70 years, Lundbeck has been at the forefront of brain science. We are committed to providing transformative therapies for brain diseases, and we are tirelessly dedicated to restoring brain health so every person can be their best. The unmet need in brain disease is vast, but we strive to see the person behind the disease, and we have deep connections with the communities we serve. In the United States, their 900+ employees support patients, families and caregivers impacted by brain diseases.
Pharmaxis is an Australian pharmaceutical research company focussed on inflammation and fibrosis with a portfolio of products at various stages of development and approval. Established in 1998 and listed on the Australian Securities Exchange in 2003 (symbol PXS) the Company’s head office, manufacturing and research laboratories are located in Sydney, Australia.
Optomed Plc is a Finnish health care technology company and one of the leading providers of handheld fundus cameras and eye-screening solutions. Optomed combines cameras with software and AI to revolutionise the diagnostic process of blinding diseases such as rapidly-increasing diabetic retinopathy. Optomed’s customers consist of international health care organisations, hospitals, and leading global medical technology companies and distributors.
Fast and Reliable Results in Cancer Diagnostics. Oncgnostics designs in-vitro diagnostic tests for the detection of DNA methylation, which is associated with a wide variety of cancers. The company uses reliable epigenetic biomarkers to create products such as GynTect®, which is a clarification test for cervical cancer and its precursors. Results are rapid, allowing clinicians to detect cancers in early stages of development. Oncgnostics implements an ISO: 13485 certified quality management system in its research, development and manufacturing processes.